News & Updates

A recent study points to interesting clinical and genetic associations with COVID-19, demonstrating that the disease continues to pose a significant public health burden with lingering adverse cardiovascular (CV) risk and genetic interaction with ABO blood types.

Treatment with osimertinib following chemoradiotherapy (CRT) helps lower the risk of distant metastases and central nervous system (CNS) disease progression in patients with unresectable stage III epidermal growth factor receptor-mutated (EGFRm) nonsmall cell lung cancer (NSCLC), results of the phase III LAURA study have shown.

Data presented at APSR 2024 demonstrate the ability of glucagon-like peptide 1 receptor agonists (GLP1-RAs) to benefit obese individuals with asthma.